New transplant approach could help more sickle cell patients
NCT ID NCT03279094
First seen Apr 26, 2026 · Last updated May 06, 2026 · Updated 1 time
Summary
This study tests a new way to do stem cell transplants for people with sickle cell disease. Instead of needing a perfectly matched donor, it uses a half-matched family donor (haploidentical). Before the transplant, patients get two rounds of immune-suppressing therapy to help the body accept the new cells. The goal is to make the transplant safer and available to more patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
Conditions
Explore the condition pages connected to this study.